-
AI, Machine Learning & Computational Biology1 month agoNetwork Bio: Building disease-specific AI models with biobank data
BIOCENTURY | EMERGING COMPANY PROFILENETWORK BIO: BUILDING DISEASE-SPECIFIC AI MODELS WITH BIOBANK DATAPalo Alto-based biotech identifying ‘barcodes’ from patient-derived tissues to model diseases over time for...
-
AI, Machine Learning & Computational Biology1 month agoAI-guided mutations help viruses infect bacteria up to 1 million times more effectively
Biochemists at the University of Wisconsin–Madison are using AI to tackle one of modern medicine's most pressing challenges: the rise of antibiotic-resistant bacterial infections. Using data...
-
AI, Machine Learning & Computational Biology1 month agoBacked by NVIDIA, Basecamp bags $140M to advance AI-designed drugs
Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.
-
AI, Machine Learning & Computational Biology1 month agoBacked by NVIDIA and Anthropic, Basecamp bags $140M to advance AI-designed drugs
Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.
-
AI, Machine Learning & Computational Biology1 month agoThe human cost of AI interviews
While artificial intelligence can help biotech and pharma companies more quickly vet job applicants, it can also turn off the very people they want to employ....
-
AI, Machine Learning & Computational Biology1 month agoTautomer-Predictor AI Tool Identifies Stable Molecules for Drug Discovery
Researchers trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where their hydrogen atoms should be positioned. The...
-
AI, Machine Learning & Computational Biology1 month agoEnveda, an AI drugmaker, banks $311M in venture funding
Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.
-
AI, Machine Learning & Computational Biology1 month agoDigital Shadows to Aid Complexity in Handling Process Intensification
AI-augmented digital twins that merely report, rather than control processes, could help biotechnology companies untangle the complexities of analyzing big multidimensional nonlinear datasets to help simplify...
-
AI, Machine Learning & Computational Biology1 month agoAI Can Spot Heart Disease, But a New Survey Warns Its Dazzling Accuracy May Be Too Good to Be True
Cardiovascular disease kills roughly 17.9 million people every year, accounting for about 32 percent of all deaths worldwide, and the World Health Organization projects that annual...
-
AI, Machine Learning & Computational Biology1 month agoAI Chemist Learns to Edit Molecules Into Makeable Medicines
Generative artificial intelligence has become remarkably good at dreaming up molecules. Feed a model a protein pocket or a desired property profile, and it will happily...
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
STAT+: HHS moves to allow compounding of some unapproved peptides
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
